HomeZYUS • CVE
add
ZYUS Life Sciences Corp
Previous close
$0.65
Year range
$0.55 - $1.00
Market cap
50.74M CAD
Avg Volume
5.90K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 120.00K | 1.69% |
Operating expense | 4.04M | -14.44% |
Net income | -4.42M | 8.06% |
Net profit margin | -3.69K | 9.60% |
Earnings per share | — | — |
EBITDA | -3.29M | 16.18% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 559.00K | -33.13% |
Total assets | 11.78M | -67.08% |
Total liabilities | 21.57M | 6.46% |
Total equity | -9.78M | — |
Shares outstanding | 78.15M | — |
Price to book | -5.00 | — |
Return on assets | -81.70% | — |
Return on capital | -242.81% | — |
Cash Flow
Net change in cash
| (CAD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -4.42M | 8.06% |
Cash from operations | -1.95M | 3.94% |
Cash from investing | 25.00K | -98.43% |
Cash from financing | 1.82M | 480.25% |
Net change in cash | -104.00K | 19.38% |
Free cash flow | -1.02M | -350.19% |
About
Founded
2018
Headquarters
Website
Employees
2
